CCM
EXAS

Camber Capital Management’s Exact Sciences EXAS Stock Holding History

Camber Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,000,000
Closed -$52.5M – 34
2017
Q4 		$52.5M Buy
+1,000,000
New +$53.4M 2.57% 15

Other funds holding EXAS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Camber Capital Management's EXAS Position: Q3 2022 in Review

Camber Capital Management sold out of Exact Sciences (EXAS) in Q3 2022, closing a stake of 300,000 shares — an estimated $11.8M sold.

Camber Capital Management first reported a position in EXAS in Q2 2022 and held it in 1 quarter. The position peaked at $11.8M in Q2 2022. 480 funds tracked by Wall St. Rank hold EXAS as of Q3 2022.

  • Camber Capital Management reported no remaining Exact Sciences position as of Q3 2022 after selling out during the quarter.
  • Camber Capital Management sold 300,000 Exact Sciences shares in Q3 2022, an estimated $11.8M.
  • Camber Capital Management first reported a position in Exact Sciences in Q2 2022 and held it in 1 quarter.
  • Camber Capital Management's Exact Sciences position peaked at $11.8M in Q2 2022.
  • 480 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2022.

Based on Camber Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.